In 1985, ARUP was a small entrepreneurial startup that set up shop in the University of Utah Research Park—which, as seen here in this 1985 photograph, still had lots of room to grow. Today, ARUP is the park’s largest resident, and the park was named Outstanding Research Park for 2020 by the Association of University Research Parks. |
March 17, 2021 |
ARUP Has a Long History and the Largest Presence in Research Park With the partial opening on February 1 of ARUP Laboratories’ new 220,000-square-foot building, the company that began in 1984 as a small, entrepreneurial startup has grown to be the largest company in University of Utah (U of U) Research Park, as measured by both physical space and number of employees. |
March 15, 2021 |
ARUP Accepting Entries for Lab Week Superhero Stories Contest Throughout the COVID-19 pandemic, laboratory professionals have undertaken a heroic effort, leaving the safety of their homes daily to wield pipettes in defense of our communities. They have worked night and day, navigated unprecedented challenges, searched out the virus in every specimen, found answers, and developed solutions. They have become superheroes in the fight against COVID-19. |
|
March 11, 2021 |
ARUP CEO Joins Lab Industry Leaders to Discuss Diversity at ACLA Meeting The widespread protests that followed the killing of George Floyd and other events last summer only strengthened ARUP Laboratories’ commitment to renew its focus on diversity and inclusion (D&I), CEO Sherrie Perkins, MD, PhD, said Wednesday, March 10, during a panel discussion about D&I in the laboratory testing industry at the American Clinical Laboratory Association (ACLA) annual meeting |
|
ARUP Chief Operations Officer Jonathan Genzen, MD, PhD, has produced a second video to explain how SARS-CoV-2 vaccines work. The new video focuses on adenovirus vaccines, including the new Johnson & Johnson vaccine. |
March 9, 2021 | Jonathan Genzen, MD, PhD, ARUP Laboratories’ chief operations officer, explains how the Johnson & Johnson SARS-CoV-2 vaccine works, and how it differs from the Moderna and Pfizer-BioNTech vaccines. |
March 2, 2021 |
A year after some of the first COVID-19 cases were detected in the United States, an expert close to both the lab and the clinical response to the pandemic reflects on some positives that have emerged from the crisis in a new LabMind podcast episode. |
|
March 1, 2021 |
Utah HERO Project Results Show COVID-19 Risk Declining, but Researchers Urge Continued Caution By the end of January, approximately 22–28% of Salt Lake County residents either had been infected with SARS-CoV-2 or had been vaccinated against the virus, according to the Utah HERO Project. |